{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T11:15:32Z","timestamp":1770462932735,"version":"3.49.0"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Finding a vaccine that can last a long time and effective against viruses with high mutation rates such as SARS-CoV-2 is still a challenge today. The various vaccines that have been available have decreased in effectiveness and require booster administration. As the professional antigen presenting cell, Dendritic Cells can also activate the immune system, especially T cells. This ability makes dendritic cells have been developed as vaccines for some types of diseases. In SARS-CoV-2 infection, T cells play a vital role in eliminating the virus, and their presence can be detected in the long term. Hence, this condition shows that the formation of T cell immunity is essential to prevent and control the course of the disease. The construction of vaccines oriented to induce strong T cells response can be formed by utilizing dendritic cells. In this article, we discuss and illustrate the role of dendritic cells and T cells in the pathogenesis of SARS-CoV-2 infection and summarizing the crucial role of dendritic cells in the formation of T cell immunity. We arrange the basis concept of developing dendritic cells for SARS-CoV-2 vaccines. A dendritic cell-based vaccine for SARS-CoV-2 has the potential to be an effective vaccine that solves existing problems.<\/jats:p>","DOI":"10.3389\/fimmu.2022.989685","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T06:43:00Z","timestamp":1662446580000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic"],"prefix":"10.3389","volume":"13","author":[{"given":"Jonny","family":"Jonny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terawan Agus","family":"Putranto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raoulian","family":"Irfon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enda Cindylosa","family":"Sitepu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/v12020135","article-title":"Return of the coronavirus: 2019-nCoV","volume":"12","author":"Gralinski","year":"2020","journal-title":"Viruses"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2021.12.014","article-title":"The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges","volume":"15","author":"Malik","year":"2022","journal-title":"J Infect Public Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12932\/AP-200220-0772","article-title":"Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic","volume":"38","author":"Prompetchara","year":"2020","journal-title":"Asian Pacific J Allergy Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00243-2","article-title":"COVID-19: immunopathogenesis and immunotherapeutics","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1126\/sciimmunol.abd6160","article-title":"SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection","volume":"5","author":"Altmann","year":"2020","journal-title":"Sci Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.10.005","article-title":"Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review","volume":"28","author":"Fiolet","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-24377-1","article-title":"SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells","volume":"12","author":"Jung","year":"2021","journal-title":"Nat Commun"},{"key":"B10","first-page":"11","article-title":"\u201cDendritic cell subsets, maturation and function.,\u201d","volume-title":"Dendritic cells.","author":"Al-Ashmawy","year":"2018"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-79427-3","article-title":"A chemokine-fusion vaccine targeting immature dendritic cells elicits elevated antibody responses to malaria sporozoites in infant macaques","volume":"11","author":"Luo","year":"2021","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00211","article-title":"NLRP3 inflammasome\u2013a key player in antiviral responses","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01441","article-title":"Immune response, inflammation, and the clinical spectrum of COVID-19","volume":"11","author":"Garc\u00eda","year":"2020","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-018-0278-1","article-title":"An introduction to immunology and immunopathology","volume":"14","author":"Marshall","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00360","article-title":"Cross-talk between antigen presenting cells and T cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis","volume":"10","author":"Gaudino","year":"2019","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01529","article-title":"Targeting conventional dendritic cells to fine-tune antibody responses","volume":"10","author":"Tesfaye","year":"2019","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1038-6","article-title":"A dynamic COVID-19 immune signature includes associations with poor prognosis","volume":"26","author":"Laing","year":"2020","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-020-00663-w","article-title":"Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)","volume":"27","author":"Chang","year":"2020","journal-title":"J BioMed Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.05.008","article-title":"Type I and type III interferons \u2013 induction, signaling, evasion, and application to combat COVID-19","volume":"27","author":"Park","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-01829-4","article-title":"IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection","volume":"4","author":"Rosa","year":"2021","journal-title":"Commun Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: Current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-17665-9","article-title":"Activation and evasion of type I interferon responses by SARS-CoV-2","volume":"11","author":"Lei","year":"2020","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.580641","article-title":"Covid-19: Perspectives on innate immune evasion","volume":"11","author":"Taefehshokr","year":"2020","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-25015-6","article-title":"SARS-CoV-2 n protein promotes NLRP3 inflammasome activation to induce hyperinflammation","volume":"12","author":"Pan","year":"2021","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01518","article-title":"Targeting the NLRP3 inflammasome in severe COVID-19","volume":"11","author":"Freeman","year":"2020","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01580","article-title":"Severe COVID-19: NLRP3 inflammasome dysregulated","volume":"11","author":"van den Berg","year":"2020","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2021.02.009","article-title":"Adaptive immune responses to SARS-CoV-2","volume":"172","author":"Forthal","year":"2021","journal-title":"Adv Drug Delivery Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01643","article-title":"Current concepts of antigen cross-presentation","volume":"9","author":"Embgenbroich","year":"2018","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.05.010","article-title":"SARS-CoV-2 human T cell epitopes : Adaptive immune response against COVID-19","volume":"29","author":"Grifoni","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00750-4","article-title":"Activation or exhaustion of CD8+ T cells in patients with COVID-19","volume":"18","author":"Rha","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/INFDIS\/JIAA150","article-title":"Characteristics of peripheral lymphocyte subset alteration in covid-19 pneumonia","volume":"221","author":"Wang","year":"2020","journal-title":"J Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.661052","article-title":"SARS-CoV-2 induces lymphocytopenia by promoting inflammation and decimates secondary lymphoid organs","volume":"12","author":"Xiang","year":"2021","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41418-022-00936-x","article-title":"T Cell apoptosis characterizes severe covid-19 disease","volume":"29","author":"Andr\u00e9","year":"2022","journal-title":"Cell Death Differ"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-05792-7","article-title":"Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-021-00681-2","article-title":"Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity","volume":"23","author":"Saichi","year":"2021","journal-title":"Nat Cell Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa356","article-title":"Attenuated interferon and proinflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation","volume":"222","author":"Yang","year":"2020","journal-title":"J Infect Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.immuni.2020.07.026","article-title":"Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses","volume":"53","author":"Zhou","year":"2020","journal-title":"Immunity"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.medj.2021.08.002","article-title":"A monocyte\/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis","volume":"2","author":"de Cevins","year":"2021","journal-title":"Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00728-2","article-title":"Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection","volume":"18","author":"P\u00e9rez-G\u00f3mez","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.761372","article-title":"Impaired dendritic cell homing in COVID-19","volume":"8","author":"Borcherding","year":"2021","journal-title":"Front Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","article-title":"Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19","volume":"182","author":"Silvin","year":"2020","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/all.15004","article-title":"A bird\u2019s eye view on the role of dendritic cells in SARS-CoV-2 infection: Perspectives for immune-based vaccines","volume":"77","author":"Galati","year":"2022","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.12.309","article-title":"SARS-CoV-2 memory b and T cell profiles in mild COVID-19 convalescent patients","volume":"115","author":"Gurevich","year":"2022","journal-title":"Int J Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2021.104986","article-title":"Dynamics of IgG-avidity and antibody levels after covid-19","volume":"144","author":"L\u00f6fstr\u00f6m","year":"2021","journal-title":"J Clin Virol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.708523","article-title":"Declining levels of neutralizing antibodies against SARS-CoV-2 in convalescent COVID-19 patients one year post symptom onset","volume":"12","author":"Xiang","year":"2021","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0402-6","article-title":"T Cell responses in patients with COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.abg5021","article-title":"Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients","volume":"6","author":"Notarbartolo","year":"2021","journal-title":"Sci Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19","volume":"21","author":"Peng","year":"2020","journal-title":"Nat Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04280-x","article-title":"Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection","author":"Adamo","year":"2021","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00743-3","article-title":"SARS-CoV-2-specific T cells in infection and vaccination","volume":"18","author":"Bertoletti","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.20202515","article-title":"Persistent cellular immunity to SARS-CoV-2 infection","volume":"218","author":"Breton","year":"2021","journal-title":"J Exp Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00625-9","article-title":"T Cell-oriented strategies for controlling the COVID-19 pandemic","volume":"21","author":"Noh","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31866-3","article-title":"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1\/2 studies from Russia","volume":"396","author":"Logunov","year":"2020","journal-title":"Lancet"},{"key":"B67","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, south Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2116185","article-title":"Efficacy and safety of NVX-CoV2373 in adults in the united states and Mexico","volume":"386","author":"Dunkle","year":"2022","journal-title":"N Engl J Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01751","article-title":"Genealogy, dendritic cell priming, and differentiation of tissue-resident memory CD8+ T cells","volume":"9","author":"Enamorado","year":"2018","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00726-4","article-title":"Dendritic cell migration in inflammation and immunity","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"B73","first-page":"1","article-title":"\u201cDendritic cell subsets and locations.,\u201d","volume-title":"International review of cell and molecular biology","author":"Balan","year":"2019"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.811968","article-title":"T Cell memory in infection, cancer, and autoimmunity","volume":"12","author":"Barnaba","year":"2022","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0465-0","article-title":"Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses","volume":"17","author":"Hilligan","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2002345117","article-title":"Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes","volume":"117","author":"Fu","year":"2020","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00009","article-title":"Are conventional type 1 dendritic cells critical for protective antitomor immunity and how","volume":"10","author":"Cance","year":"2019","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.01.072","article-title":"Suppression of Tcf1 by inflammatory cytokines facilitates effector CD8 T cell differentiation","volume":"22","author":"Danilo","year":"2018","journal-title":"Cell Rep"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01887","article-title":"Monocyte-derived dendritic cells dictate the memory differentiation of CD8+ T cells during acute infection","volume":"10","author":"Shin","year":"2019","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1901046","article-title":"Monocyte-derived cells in tissue-resident memory T cell formation","volume":"204","author":"Chu","year":"2020","journal-title":"J Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3390\/v13091839","article-title":"Type I interferon induction and exhaustion during viral infection: Plasmacytoid dendritic cells and emerging COVID-10 findings","volume":"13","author":"Greene","year":"2021","journal-title":"Viruses"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03176","article-title":"Human dendritic cells: Their heterogeneity and clinical application potential in cancer immunotherapy","volume":"10","author":"Patente","year":"2019","journal-title":"Front Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110365","article-title":"Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19","volume":"146","author":"Saadeldin","year":"2021","journal-title":"A hypothesis. Med Hypotheses"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00766","article-title":"Personalized dendritic cell vaccines-recent breakthroughs and encouraging clinical results","volume":"10","author":"Mastelic-Gavillet","year":"2019","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aao5931","article-title":"Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer","volume":"10","author":"Tanyi","year":"2018","journal-title":"Sci Transl Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02993","article-title":"Using dendritic cell-based immunotherapy to treat HIV: How can this strategy be improved","volume":"9","author":"da Silva","year":"2018","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"15006","DOI":"10.1038\/mtm.2015.6","article-title":"Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis c virus infection","volume":"2","author":"Zabaleta","year":"2015","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aaf9194.Influenza","article-title":"Influenza vaccines differentially regulate the interferon response in human dendritic cells subset","volume":"9","author":"Ahn","year":"2017","journal-title":"Sci Transl Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1689081","article-title":"And humoral immune responses","volume":"16","author":"George","year":"2020","journal-title":"vivo. Hum Vaccines Immunother"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-398381-7.00029-0","article-title":"Role of dendritic cells in the adaptive immune response","author":"Moticka","year":"2016","journal-title":"A Hist Perspect Evidence-Based Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/SCITRANSLMED.ABC3539","article-title":"Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits","volume":"12","author":"Ravichandran","year":"2020","journal-title":"Sci Transl Med"},{"key":"B92","volume-title":"Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. why should it be ex vivo? Expert Review of Vaccine,","author":"Jonny","year":"2022"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2015.11.002","article-title":"Cross-dressing: An alternative mechanism for antigen presentation","volume":"168","author":"Campana","year":"2015","journal-title":"Immunol Lett"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0076801","article-title":"Intracellular regulation of cross-presentation during dendritic cell maturation","volume":"8","author":"Wagner","year":"2013","journal-title":"PloS One"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1080\/08830185.2020.1844195","article-title":"Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome","volume":"40","author":"Borges","year":"2021","journal-title":"Int Rev Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.654587","article-title":"Plasmacytoid dendritic cells depletion and elevation of IFN-\u03b3 dependent chemokines CXCL9 and CXCL10 in children with multisystem inflammatory syndrome","volume":"12","author":"Caldarale","year":"2021","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.843342","article-title":"Depletion and dysfunction of dendritic cells: Understanding SARS-CoV-2 infection","volume":"13","author":"Chang","year":"2022","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800986","article-title":"With a little help from T follicular helper friends: Humoral immunity to influenza vaccination","volume":"202","author":"Koutsakos","year":"2019","journal-title":"J Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coi.2019.04.003","article-title":"Antigen presentation by dendritic cells for b cell activation","volume":"58","author":"Heath","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-021-00657-1","article-title":"The germinal centre b cell response to SARS-CoV-2","volume":"22","author":"Laidlaw","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1134\/S0026893317050132","article-title":"Maturation and antigen loading protocols influence activity of anticancer dendritic cells","volume":"52","author":"Nazarkina","year":"2018","journal-title":"Mol Biol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcdb.2017.12.009","article-title":"Dendritic cell subsets","volume":"84","author":"Macri","year":"2018","journal-title":"Semin Cell Dev Biol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-020-0415-5","article-title":"Ex-vivo pulsed dendritic cell vaccination against cancer","volume":"41","author":"Zhuo","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2019-000474","article-title":"Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103 + conventional dendritic cells","volume":"8","author":"Zhou","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1172\/JCI.INSIGHT.135143","article-title":"IL-12 from endogenous cDC1, and not Is required for Th1 induction","volume":"5","author":"Ashour","year":"2020","journal-title":"JCI Insight"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011144","article-title":"CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells","volume":"5","author":"Yewdall","year":"2010","journal-title":"PloS One"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.701501","article-title":"SARS-CoV-2 vaccines based on the spike glycoprotein and implications of new viral variants","volume":"12","author":"Mart\u00ednez-Flores","year":"2021","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: A comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2022.01.007","article-title":"Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity","volume":"15","author":"Alefishat","year":"2022","journal-title":"J Infect Public Health"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.abj1750","article-title":"SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees","volume":"6","author":"Geers","year":"2021","journal-title":"Sci Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166432","article-title":"Mutations in spike protein T cell epitopes of SARS-CoV-2 variants: Plausible influence on vaccine efficacy","volume":"1868","author":"Sankaranarayanan","year":"2022","journal-title":"Mol Basis Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.989685\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T06:43:08Z","timestamp":1662446588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.989685\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":111,"alternative-id":["10.3389\/fimmu.2022.989685"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.989685","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"article-number":"989685"}}